SCHEMBL23635989

SCHEMBL23635989

O=C(O)c1cc(OC(=O)c2cc(OCc3ccc4c(c3)OC(c3ccccc3)(c3ccccc3)O4)c3c(c2)OC(c2ccccc2)(c2ccccc2)O3)c2c(c1)OC(c1ccccc1)(c1ccccc1)O2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 6/20 0.40
CNR1 P21554 2/20 0.40
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35
TP53 P04637 1/20 0.35
XBP1 P17861 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SRD5A1 P18405 1/20 0.35
SRD5A2 P31213 1/20 0.35
HIF1A Q16665 1/20 0.35
RXRA P19793 4/20 0.35
RXRB P28702 3/20 0.35
RXRG P48443 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30257818 0.93 MEN1 (0.42) MRGPRX4KMT2AMEN1HPGDSRD5A2
SCHEMBL21584456 0.93 MEN1 (0.42) MRGPRX4KMT2AMEN1HPGDSRD5A2
SCHEMBL30257817 0.93 MEN1 (0.42) MRGPRX4KMT2AMEN1HPGDSRD5A2
SCHEMBL23957504 0.93 MEN1 (0.42) MRGPRX4KMT2AMEN1HPGDSRD5A2
SCHEMBL24621932 0.87 SIRT1 (0.42) MRGPRX4KMT2AMEN1HPGDHIF1A
SCHEMBL9057677 0.86 MEN1 (0.48) MRGPRX4KMT2AMEN1HPGDNPC1
SCHEMBL23630711 0.86 HIF1A (0.44) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL30307866 0.85 KMT2A (0.42) CNR1KMT2AMEN1SMN1; SMN2TDP1
SCHEMBL29706710 0.85 HIF1A (0.39) MRGPRX4KMT2AMEN1HPGDNPC1
SCHEMBL23630721 0.84 HIF1A (0.44) KMT2AMEN1SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) 2021-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210214385-A1 INHIBITORS OF D-AMINO ACID OXIDASE AND USES THEREOF DAO, DDO, DDC MRGPRX4 1383/4885CNR1 2308/4885KMT2A 1692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.